XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 42.7

Change

-0.04 (-0.09)%

Market Cap

CAD 0.59B

Volume

3.24K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.14 (+0.10%)

CAD 21.96B
ZSP:CA BMO S&P 500

+0.17 (+0.19%)

CAD 18.70B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.41 (+0.70%)

CAD 11.35B
VUN:CA Vanguard US Total Market

+0.22 (+0.20%)

CAD 11.29B
XUS:CA iShares Core S&P 500 Index ETF

+0.08 (+0.15%)

CAD 8.82B
HXS:CA Global X S&P 500 Corporate Cla..

+0.02 (+0.02%)

CAD 4.70B
VSP:CA Vanguard S&P 500 CAD hedged

+0.64 (+0.70%)

CAD 4.14B
QUU:CA Mackenzie US Large Cap Equity ..

+0.94 (+0.40%)

CAD 3.65B
XUU:CA iShares Core S&P US Total Mark..

+0.24 (+0.40%)

CAD 3.46B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.30 (+0.61%)

CAD 3.34B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.92% 12% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.92% 12% F 23% F
Trailing 12 Months  
Capital Gain 15.53% 67% D+ 76% C+
Dividend Return 1.00% 30% F 13% F
Total Return 16.53% 66% D+ 71% C-
Trailing 5 Years  
Capital Gain 135.00% 81% B- 76% C+
Dividend Return 8.59% 21% F 11% F
Total Return 143.59% 75% C 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 15.39% 78% C+ 79% B-
Dividend Return 16.29% 75% C 77% C+
Total Return 0.89% 30% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 15.74% 37% F 54% F
Risk Adjusted Return 103.46% 61% D- 94% A
Market Capitalization 0.59B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.